BETIX

This brand name is authorized in Nigeria.

Active ingredients

The drug BETIX contains one active pharmaceutical ingredient (API):

1	Glimepiride UNII 6KY687524K - GLIMEPIRIDE
	Glimepiride is an orally active hypoglycaemic substance belonging to the sulphonylurea group. It may be used in non-insulin dependent (type 2) diabetes mellitus. Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.
	Read more about Glimepiride

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100968	Tablet	Betix 4 mg Tablets TAB 4 mg 10 x 10's (in blisters)	Film-coated tablet	31/07/2024
B4-7578	Tablet	Betix 2mg TAB 2 mg 3X10	28 RNW-PP-292728 Betix 2mg GLIMEPIRIDE Glimepiride 2mg , Excipients -Microcrystalline Cellulose PH 102 Talcum Powder Magnesium Stearate Cross Carmellose Sodium Colloidal Anhydrous Silica Sodium Starch Glycolate Colour Coat FC4S-H Iso Propyl Alcohol Methylene Chloride B4-7578 Drugs Imported Products 310 Prescription Only Medicine (POM) 10/29/2022 TAKKI HEALTHCARE LIMITED, MAZADO PLAZA SHETIMA MUNGONO CRESCENT OFF NGOZI IWEALA STREET, UTAKO ABUJA FCT 0 takihealth@gmail.com ALCHEMY MEDICINE PVT LTD>16636, KHASRA NO. 44, VILLAGE KHELPUR, NASRULLA CHUDIYALA ROAD, BHAGWANPUR, ROOKEE, HARIDWAR UTTARAKHAND , INDIA, India	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BB12	Glimepiride	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100968, B4-7578